Riskpilot← Back to searchSign inGet full accessRANDESUND LEGESENTER AS
ASActiveOrg 925300624Lauvåsen hovedvei 1, 4656 HamresandenGeneral medical practice activities · NACE 8621Est. 20208 employees
Revenue 2024
NOK 5M
+6% vs 2023
EBITDA margin
0.2%
-56% vs 2023
Equity ratio
1.6%
Financial strength
Net profit 2024
NOK 0
8 employees
| Revenue | NOK 5M | +6% |
| EBITDA | NOK 8K | -56% |
| Net profit | NOK 0 | — |
| Total assets | NOK 1,7M | -22% |
| Equity | NOK 27K | +0% |
| Employees | 8 | — |
Legal name
RANDESUND LEGESENTER AS
Org number
925300624
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
8. juli 2020
Share capital
NOK 36 000
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Drive legesenter samt alt hva dermed står i forbindelse, herunder gjennom aksjetegning eller på annen måte å delta i andre selskaper eller foretak.
Address
Lauvåsen hovedvei 1, 4656 Hamresanden
Phone
+4738148350
Email
anton.rodahl@randesundhelse.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 194 | 4 816 | 4 486 | 4 692 | 4 969 |
| Staff expenses | −2 706 | −3 070 | −2 946 | −3 108 | −3 320 |
| EBITDA | 41 | 44 | 29 | 17 | 8 |
| Depreciation & amort. | −44 | −44 | −31 | −21 | −15 |
| EBIT | −4 | 0 | −1 | −4 | −7 |
| Net financials | 4 | −0 | 1 | 4 | 7 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | 0 | 0 | 0 | 0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 213 | 845 | 1 223 | 2 219 | 1 726 |
| Equity | 27 | 27 | 27 | 27 | 27 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 185 | 818 | 1 195 | 2 191 | 1 698 |
| Total debt | 1 185 | 818 | 1 195 | 2 191 | 1 698 |
EBITDA margin
0.2%
This company
15.8%
Market median
-99% vs market
20202024
Equity ratio
1.6%
This company
38.2%
Market median
-96% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
2.88×
This company
1.12×
Market median
+157% vs market
20202024
Debt / equity
61.91×
This company
0.62×
Market median
-9885% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-04-20 – 2020-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 16.7% | 16.7% | 2024 | |
| Individual | 16.7% | 16.7% | 2024 | |
| Individual | 16.7% | 16.7% | 2024 | |
| Individual | 16.7% | 16.7% | 2024 | |
| Individual | 16.7% | 16.7% | 2024 | |
| Individual | 16.7% | 16.7% | 2022 | |
| Individual | 16.7% | 16.7% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RANDESUND LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Vegar Tegle Skjærvø | Board of Directors | 0 companies |
| Anton Rodahl | Chairman | 0 companies |
| Nils Christian Tvedt Karlsen | Board of Directors | 0 companies |